GBFFX
GMO Benchmark-Free Fund
GMO TRUST
Expense ratio1
0.56%
Net assets2
$1.30B
Holdings2
983
Category
International Equity
2025 return3
24.06%

Investment objective & strategy

As of June 30, 2025 · prospectus

Objective. Positive total return.

Strategy. The investment strategies GMO pursues for the Fund are intended to complement the strategies it is pursuing for the other accounts it manages. Accordingly, the Fund is not intended to serve as a standalone investment. The Fund invests its assets in direct investments, shares of other series of GMO Trust, including the Equity Funds, the Fixed Income Funds, the Implementation Funds, and the Alternative Funds, and shares of GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO seeks to achieve the Funds investment objective by investing the Funds assets in asset classes GMO believes offer the most attractive risk-adjusted returns. GMO uses its quantitative multi-year forecasts … The investment strategies GMO pursues for the Fund are intended to complement the strategies it is pursuing for the other accounts it manages. Accordingly, the Fund is not intended to serve as a standalone investment. The Fund invests its assets in direct investments, shares of other series of GMO Trust, including the Equity Funds, the Fixed Income Funds, the Implementation Funds, and the Alternative Funds, and shares of GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO seeks to achieve the Funds investment objective by investing the Funds assets in asset classes GMO believes offer the most attractive risk-adjusted returns. GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMOs expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over a complete market cycle. GMO changes the Funds asset class exposures in response to changes in GMOs investment outlook and its assessment of market valuations and may use redemptions or purchases of Fund shares to rebalance the Funds investments. The factors GMO considers and investment methods GMO uses can change over time. GMO does not manage the Fund to, or control the Funds risk relative to, any securities index or securities benchmark. The Fund is permitted to invest in any asset class (e.g., U.S. equity, non-U.S. equity, emerging country equity, U.S. fixed income, non-U.S. fixed income, emerging country debt, and commodities), strategy (e.g., long/short and event-driven strategies), sector, country, or region, and at times may have substantial exposure to a single asset class, sector, country, region, issuer, or currency and companies with similar market capitalizations. In addition, the Fund is not restricted in its exposure to any particular market and may invest in securities of companies of any market capitalization and, in the case of debt instruments, of any credit quality (including below investment grade securities, commonly referred to as high yield or junk bonds), maturity and duration. GMOs ability to shift investments among asset classes is not subject to any limits. The Fund typically has substantial exposure to derivatives and short-sales. Leverage is not a principal component of the Funds investment strategy. However, because of its derivative exposure, the Fund may at times have gross investment exposure in excess of its net assets (i.e., the Fund may be leveraged) and, therefore, may be subject to higher risk of loss during those times than if the Fund were not leveraged. In seeking to achieve the Funds investment objective, GMO may invest a significant portion of the Funds net assets in cash and cash equivalents. In addition, the Fund may lend its portfolio securities. The Fund also may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.

Top holdings

As of Feb. 28, 2026 · N-PORT
SecurityTickerValue% of fund
NOMURA TREAS TRIPARTY $190.00M 14.67%
GMO Alternative Allocation Fund $163.83M 12.65%
U.S. Treasury Notes $59.65M 4.60%
U.S. Treasury Floating Rate Notes $55.25M 4.26%
U.S.Treasury Notes $55.07M 4.25%
U.S. Treasury Notes $53.89M 4.16%
GMO Resources Fund VI GMOWX $39.65M 3.06%
GMO Opportunistic Income Fund $23.56M 1.82%
TSMC $19.41M 1.50%
GMO Climate Change Fund $13.35M 1.03%
View all holdings →

Allocation by sector

As of February 28, 2026 · N-PORT
View portfolio breakdown →

Portfolio moves

Nov 30, 2025 → Feb 28, 2026
Opened
177
Exited
136
Increased
340
Decreased
351
Unchanged
313

How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.

View portfolio moves →

Similar funds

Funds whose portfolios most overlap this one, by weight
FundOverlapNet exp.
GMO Implementation Fund · GIMFX 75% 0.41%
GMO Alternative Allocation Fund · GAAVX, GAAKX, GAAGX 33% 2.03%
GMO Asset Allocation Bond Fund · GMOBX, GABFX 22% 0.39%
View all similar funds →

Advisers

As of February 28, 2025 · N-CEN
FirmRole
Grantham Mayo van Otterloo & Co LLC Adviser

Footnotes

  1. Expense ratio as of June 30, 2025, from the fund's prospectus.
  2. Net assets and holdings count as of February 28, 2026, from the fund's N-PORT filing.
  3. Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.